Integrated palliative care with early clinical trial: what oncologists say and what patients understand
Mathilde Lochmann(Centre Léon Bérard), Véronique Christophe(Université Claude Bernard Lyon 1), Philippe A. Cassier(Lyon College), Bénédicte Mastroïanni(Centre Léon Bérard), Magali Girodet(Université Claude Bernard Lyon 1), Julie Duranti(Centre Léon Bérard), Armelle Vinceneux(Centre Léon Bérard), Valentine Baudry(Université Claude Bernard Lyon 1), Johanna Despax(Centre Léon Bérard), Loïc Verlingue(Université Paris-Sud), Olivier Renard(Centre Léon Bérard), Mona Amini-Adle(Centre Léon Bérard), Mehdi Brahmi, Amélie Anota(Centre Léon Bérard), Gisèle Chvetzoff(Université Claude Bernard Lyon 1), Julien Gautier(Centre Léon Bérard), F. Ducimetiere(Centre Léon Bérard), Aurélie Swadulz(Centre Léon Bérard), Hélène Vanacker(Centre Léon Bérard)
Cited by 0
Related Papers
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
|Cell Research|2019|246